FR2190414B1 - - Google Patents

Info

Publication number: FR2190414B1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

FR7320833A

Other versions

FR2190414A1 (fr

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-07-01

Filing date

1973-06-07

Publication date

1976-07-02

1973-06-07 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

1974-02-01 Publication of FR2190414A1 publication Critical patent/FR2190414A1/fr

1976-07-02 Application granted granted Critical

1976-07-02 Publication of FR2190414B1 publication Critical patent/FR2190414B1/fr

Status Expired legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FR7320833A 1972-07-01 1973-06-07 Expired FR2190414B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP6630172A JPS5512435B2 (fr)	1972-07-01	1972-07-01

Publications (2)

Publication Number	Publication Date
FR2190414A1 FR2190414A1 (fr)	1974-02-01
FR2190414B1 true FR2190414B1 (fr)	1976-07-02

Family

ID=13311838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR7320833A Expired FR2190414B1 (fr)	1972-07-01	1973-06-07

Country Status (15)

Country	Link
US (1)	US3925357A (fr)
JP (1)	JPS5512435B2 (fr)
AT (1)	AT325206B (fr)
AU (1)	AU469986B2 (fr)
BE (1)	BE801588A (fr)
CA (1)	CA996548A (fr)
CH (1)	CH573435A5 (fr)
CS (1)	CS168036B2 (fr)
DE (1)	DE2332840A1 (fr)
FR (1)	FR2190414B1 (fr)
GB (1)	GB1386566A (fr)
HU (1)	HU166029B (fr)
NL (1)	NL7308048A (fr)
PL (1)	PL92969B1 (fr)
SE (1)	SE402916B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5522148U (fr) *	1978-07-29	1980-02-13
DK1368349T3 (da) *	2001-02-24	2007-05-21	Boehringer Ingelheim Pharma	Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler
US20030171424A1 (en) *	2002-03-07	2003-09-11	Lin Ai J.	Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) *	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) *	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) *	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (fr)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	Compositions d'inhibiteurs de la DPP IV
CN101437823B (zh) *	2006-05-04	2014-12-10	勃林格殷格翰国际有限公司	多晶型
PE20110235A1 (es) *	2006-05-04	2011-04-14	Boehringer Ingelheim Int	Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP2190434B1 (fr) *	2007-08-17	2019-04-17	Boehringer Ingelheim International GmbH	Utilisation de derives de la purine pour leur utilisation dans le traitement des maladies liees a fap
AR071175A1 (es)	2008-04-03	2010-06-02	Boehringer Ingelheim Int	Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) *	2008-06-03	2010-02-23	Boehringer Ingelheim Int	Tratamiento de nafld
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt)	2008-08-06	2020-12-15	Boehringer Ingelheim International Gmbh	Inibidor de dpp-4 e seu uso
AU2009281122C1 (en) *	2008-08-15	2016-04-21	Boehringer Ingelheim International Gmbh	Purin derivatives for use in the treatment of fab-related diseases
EP2344195A2 (fr)	2008-09-10	2011-07-20	Boehringer Ingelheim International GmbH	Polythérapie pour le traitement du diabète et des états pathologiques apparentés
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
NZ592924A (en)	2008-12-23	2014-05-30	Boehringer Ingelheim Int	Salt forms of a xanthine derivative
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
BR112012012641A2 (pt)	2009-11-27	2020-08-11	Boehringer Ingelheim International Gmbh	TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA
MX341025B (es)	2010-05-05	2016-08-04	Boehringer Ingelheim Int Gmbh *	Terapia de combinacion.
ES2802243T3 (es)	2010-06-24	2021-01-18	Boehringer Ingelheim Int	Terapia para la diabetes
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
EP3517539B1 (fr)	2011-07-15	2022-12-14	Boehringer Ingelheim International GmbH	Dérivé de quinazoline dimère substitué, sa préparation et son utilisation dans des compositions pharmaceutiques pour le traitement du diabète de type i et ii
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
WO2013171167A1 (fr)	2012-05-14	2013-11-21	Boehringer Ingelheim International Gmbh	Dérivé de xanthine en tant qu'inhibiteur de dpp-4 pour l'utilisation dans le traitement de troubles associés aux podocytes et/ou un syndrome néphrotique
WO2013174767A1 (fr)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires
WO2015128453A1 (fr)	2014-02-28	2015-09-03	Boehringer Ingelheim International Gmbh	Utilisation médicale d'un inhibiteur de dpp-4
AU2017276758A1 (en)	2016-06-10	2018-11-08	Boehringer Ingelheim International Gmbh	Combinations of Linagliptin and metformin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1026793A (fr) *	1949-08-02	1953-05-04	American Cyanamid Co	Procédé de préparation de sels de pénicilline
NL6803062A (fr) *	1967-03-10	1968-09-11
US3557094A (en) *	1968-01-05	1971-01-19	Pfizer & Co C	Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) *	1968-09-28	1971-05-15	Takeda Chemical Industries Ltd	Verfahren zur herstellung neuer penicilline

1972
- 1972-07-01 JP JP6630172A patent/JPS5512435B2/ja not_active Expired
1973
- 1973-06-01 HU HUTA1257A patent/HU166029B/hu unknown
- 1973-06-07 FR FR7320833A patent/FR2190414B1/fr not_active Expired
- 1973-06-08 NL NL7308048A patent/NL7308048A/xx not_active Application Discontinuation
- 1973-06-19 US US371528A patent/US3925357A/en not_active Expired - Lifetime
- 1973-06-25 CS CS4540A patent/CS168036B2/cs unknown
- 1973-06-28 DE DE2332840A patent/DE2332840A1/de active Pending
- 1973-06-28 BE BE132836A patent/BE801588A/fr unknown
- 1973-06-28 SE SE7309138A patent/SE402916B/xx unknown
- 1973-06-29 AT AT576473A patent/AT325206B/de not_active IP Right Cessation
- 1973-06-29 CH CH955873A patent/CH573435A5/xx not_active IP Right Cessation
- 1973-06-29 CA CA175,329A patent/CA996548A/en not_active Expired
- 1973-07-02 PL PL1973163783A patent/PL92969B1/pl unknown
- 1973-07-02 GB GB3147473A patent/GB1386566A/en not_active Expired
- 1973-07-02 AU AU57600/73A patent/AU469986B2/en not_active Expired

Also Published As

Publication number	Publication date
JPS4925121A (fr)	1974-03-06
NL7308048A (fr)	1974-01-03
CH573435A5 (fr)	1976-03-15
SE402916B (sv)	1978-07-24
AU469986B2 (en)	1976-02-26
CS168036B2 (fr)	1976-05-28
FR2190414A1 (fr)	1974-02-01
AU5760073A (en)	1975-01-09
CA996548A (en)	1976-09-07
DE2332840A1 (de)	1974-01-17
US3925357A (en)	1975-12-09
JPS5512435B2 (fr)	1980-04-02
HU166029B (fr)	1974-12-28
BE801588A (fr)	1973-12-28
GB1386566A (en)	1975-03-12
PL92969B1 (fr)	1977-04-30
AT325206B (de)	1975-10-10

Legal Events

Date	Code	Title	Description
1980-04-04	ST	Notification of lapse

Publication	Publication Date	Title
FR2190414B1 (fr)	1976-07-02
FR2201369A1 (fr)	1974-04-26
JPS4884036A (fr)	1973-11-08
JPS492301U (fr)	1974-01-10
JPS4842181Y1 (fr)	1973-12-07
JPS4977968U (fr)	1974-07-05
CH561468A5 (fr)	1975-04-30
CH559429A5 (fr)	1975-02-28
CH569902A5 (fr)	1975-11-28
CH569801A5 (fr)	1975-11-28
CH569291A5 (fr)	1975-11-14
CH569273A5 (fr)	1975-11-14
CH567237A5 (fr)	1975-09-30
CH566592A5 (fr)	1975-09-15
CH565672A5 (fr)	1975-08-29
CH565409A5 (fr)	1975-08-15
CH562536A5 (fr)	1975-05-30
CH562078A5 (fr)	1975-05-30
CH561373A5 (fr)	1975-04-30
BG19715A1 (fr)	1975-10-10
CH561134A5 (fr)	1975-04-30
CH560238A5 (fr)	1975-03-27
CH560126A5 (fr)	1975-03-27
CH569854A5 (fr)	1975-11-28
CH559375A5 (fr)	1975-02-28